AbbVie

News

Chronic lymphocytic leukemia (CLL) is a type of cancer of the blood and bone marrow - the spongy tissue inside bones where blood cells are made.

AbbVie's CLL drug Venclyxto too expensive for NHS, says NICE

NICE has said AbbVie’s Venclyxto (venetoclax), in combination with development partner Roche's MabThera/Rituxan (rituximab), is not a cost-effective use of NHS resources as a treatment for

News

Samsung Bioepis' Humira biosimilar launches in EU

Samsung Bioepis has become the latest biosimilars company to confirm it has launched a cheaper near-copy of AbbVie’s Humira inflammatory diseases blockbuster, after its European patent expi

News

Billions up for grabs as EU patent on AbbVie's Humira expire...

The patent for Humira, the world’s bestselling drug, expires in Europe today – opening the door for a host of cheaper biosimilars to hit the market.

News

Sandoz free to launch Humira biosimilar following AbbVie dea...

Novartis’ generics and biosimilars arm, Sandoz, has confirmed it is to launch its biosimilar of AbbVie’s Humira (adalimumab) in Europe this year after the two companies settled intellectual

News

Humira developer Winter among Nobel chemistry prize winners

A scientist who pioneered the technology used to discover the biggest selling drug in the world, AbbVie’s Humira, was among a trio who received this year’s Nobel Prize in Chemistry.

News

Mylan and Fujifilm join Humira bunfight as fifth EU biosimil...

Mylan and Fujifilm Kyowa Kirin Biologics have got their Humira biosimilar approved in Europe – the fifth cut-price competitor approved ahead of patent expiry on AbbVie’s inflammatory diseas

AbbVie's CLL drug Venclyxto too expensive for NHS, says NICE

Samsung Bioepis' Humira biosimilar launches in EU

Billions up for grabs as EU patent on AbbVie's Humira expire...

Sandoz free to launch Humira biosimilar following AbbVie dea...

Humira developer Winter among Nobel chemistry prize winners

Mylan and Fujifilm join Humira bunfight as fifth EU biosimil...

Europe is facing a surge in STIs, says ECDC

Discover a new era of healthcare panel engagement: Grounded ...

AbbVie

Editor's Picks